Lv1
50 积分 2024-01-03 加入
加油，加油！
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
10天前
已完结
Balancing Multivalent Avidity and Receptor Availability Governs mRNA Delivery by Antibody-Functionalized Lipid Nanoparticles
2个月前
已完结
Overcoming ovarian cancer resistance and evasion to CAR-T cell therapy by harnessing allogeneic CAR-NKT cells
3个月前
已完结
Allogeneic CD19-targeted CAR-T therapy in refractory systemic lupus erythematosus achieved durable remission
3个月前
已完结
Interleukin-17A promotes the growth of human germinal center derived non-Hodgkin B cell lymphoma
4个月前
已完结
EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models
5个月前
已完结
NOD/SCID IL2Rγ-null mouse xenograft model of human p53-mutated chronic lymphocytic leukemia and ATM-mutated mantle cell lymphoma using permanent cell lines
5个月前
已完结
Figure S7 from Oral IRAK-4 Inhibitor CA-4948 Is Blood-Brain Barrier Penetrant and Has Single-Agent Activity against CNS Lymphoma and Melanoma Brain Metastases
5个月前
已完结
Patient‐derived xenograft mouse models to investigate tropism to the central nervous system and retina of primary and secondary central nervous system lymphoma
5个月前
已完结
Nanoparticles hijack calvarial immune cells for CNS drug delivery and stroke therapy
5个月前
已完结
皖公网安备34019202002308
